BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12646839)

  • 21. CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas.
    Kullar PJ; Pearson DM; Malley DS; Collins VP; Ichimura K
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):505-14. PubMed ID: 20831745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular biological analysis of neurofibromatosis type 2 gene].
    Ichimura K; Yuasa Y
    Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
    Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
    Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery.
    Lee DJ; Maseyesva B; Westra W; Long D; Niparko JK; Califano J
    Otol Neurotol; 2006 Feb; 27(2):213-9. PubMed ID: 16436992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular biology and novel treatments of vestibular schwannomas.
    Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
    J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurotrophic factor expression in vestibular schwannoma. An overview].
    Diensthuber M; Lenarz T; Stöver T
    Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Type 2 neurofibromatosis without acoustic neuroma].
    Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
    Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.
    Evans DG; Maher ER; Baser ME
    J Med Genet; 2005 Aug; 42(8):630-2. PubMed ID: 16061561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
    Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
    Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genesis and biology of vestibular schwannomas.
    Roche PH; Bouvier C; Chinot O; Figarella-Branger D
    Prog Neurol Surg; 2008; 21():24-31. PubMed ID: 18810196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
    Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
    Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates on Tumor Biology in Vestibular Schwannoma.
    Nourbakhsh A; Dinh CT
    Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
    Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
    J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.